Development of Antibody for Gene Therapy

Based on "integrated R&D platform for innovative antibody drugs" and "super-trillion innovative antibody discovery platform". We can customize the screening strategies for the best antibody candidates suitable for gene therapy. We also provide all-in-one R&D services from target to gene therapeutic antibody.

Service Highlights

1. Integrated platform for innovative antibody drug discovery

• l 10 functional modules and 25+ sub-platforms covering the whole procedure of drug discovery

• l Project with comprehensive arrangement; PCC can be completed in 12 months

2. Distinctive capability for multi-route antibody discovery

• l Trillion-capacity antibody library; thousands of leads can be obtained for common targets

• l Diversified antibody sources: human recombinant library, semi-synthetic trillion-capacity VHH library, mouse immune library, alpaca immune VHH library, polypeptide library, and common light chain library

• l Full coverage of antibody types: full human antibody, single domain antibody, common light chain bispecific antibody, mouse monoclonal antibody, and rat monoclonal antibody

• l Antibody types: IgG, Fab, VHH

3. Extensive project experience

• l 20+ scientists expertized in various fields with the capability of systematic review of specific project

• l 100+ projects experience and high success rate

4. Customized service

• l Combination of innovative target / linker / intracellular nucleic acid

• l Integrated service platform in the antibody development